SECsense Logo

Y-MABS Therapeutics 8-K Report: Key Updates from January 13, 2025

$YMAB
Form 8-K
Filed on: 2025-01-13
Source
Y-MABS Therapeutics 8-K Report: Key Updates from January 13, 2025

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Y-MABS Therapeutics, Inc.
  • CIK Number: 0001722964
  • Incorporation State: Delaware (DE)
  • SEC File Number: 001-38650
  • Employer Identification Number (EIN): 47-4619612
  1. Contact Details:
  • Address: 230 Park Avenue, Suite 3350, New York, NY 10169
  • Phone Number: 646-885-8505
  1. Filing Information:
  • Filing Type: 8-K
  • Filing Date: January 13, 2025
  1. Security Information:
  • Type of Security: Common Stock
  • Par Value: $0.0001
  • Ticker Symbol: YMAB
  • Exchange: NASDAQ
  1. Period Information:
  • Filing Period: The report covers a single day, January 13, 2025.

Summary:

This filing is an 8-K submission by Y-MABS Therapeutics, Inc., indicating a significant event or change that occurred on January 13, 2025. The report is filed with the SEC and includes standard company and contact information. The company is publicly traded on NASDAQ under the ticker symbol YMAB, with a nominal par value for its common stock.